1.
Boesjes CM, van der Gang LF, Zuithoff NP, Bakker DS, Spekhorst LS, Haeck I, et al. Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry. Acta Derm Venereol [Internet]. 2023 Feb. 16 [cited 2024 Nov. 23];103:adv00872. Available from: https://medicaljournalssweden.se/actadv/article/view/5243